Novo Nordisk A/S (ADR)  

(Public, NYSE:NVO)   Watch this stock  
Find more results for NVO
44.96
-0.29 (-0.64%)
After Hours: 44.96 0.00 (0.00%)
Apr 23, 5:16PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 44.89 - 45.29
52 week 29.90 - 48.42
Open 45.23
Vol / Avg. 454,949.00/1.37M
Mkt cap 119.40B
P/E 26.00
Div/yield 0.83/1.85
EPS 1.73
Shares 2.66B
Beta 0.93
Inst. own 6%
Mar 17, 2014
Novo Nordisk A/S Annual Shareholder Meeting
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 27.90% 30.13%
Operating margin 33.89% 37.68%
EBITD margin - 41.03%
Return on average assets 35.07% 37.03%
Return on average equity 59.44% 60.54%
Employees 37,978 -
CDP Score - 96 B

Address

Novo Alle
BAGSVAERD, 2880
Denmark
+45-44-448888 (Phone)
+45-44-436633 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Novo Nordisk A/S is a healthcare company. The Company is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. It is engaged in diabetes care. It has a range of diabetes product portfolio, including a portfolio of modern insulins and the first human once-daily GLP-1 analog. In addition, it has is engaged in areas, such as haemophilia, growth hormone therapy and hormone replacement therapy. It manufactures and markets pharmaceutical products and services to patients, the medical profession and society. The Company operates in two segments: diabetes care and biopharmaceuticals. In February 2014, Innate Pharma has acquired full development and commercialization rights to the anti-NKG2A antibody, a immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.

Officers and directors

Goran A. Ando M.D. Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Kaare Schultz President, Chief Operating Officer
Age: 52
Bio & Compensation  - Reuters
Lars Rebien Soerensen Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Jeppe Christiansen Vice Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
Jesper Brandgaard Chief Financial Officer, Executive Vice President
Age: 50
Bio & Compensation  - Reuters
Lars Fruergaard Joergensen Executive Vice President, Chief Information Officer
Age: 47
Bio & Compensation  - Reuters
Mads Krogsgaard Thomsen Chief Science Officer, Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Jakob Riis Executive Vice President of Marketing & Medical Affairs
Age: 47
Bio & Compensation  - Reuters
Lise Kingo Executive Vice President, Chief of Staffs
Age: 52
Bio & Compensation  - Reuters
Liselotte Hyveled Director, Employee Representative
Bio & Compensation  - Reuters